chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Within a few hours, had a herpes outbreak.; This is a spontaneous report from a non-contactable consumer, the patient. A 44-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EW0178) via an unspecified route of administration in the left arm on 24May2021 at 14:00 (at the age of 44-years-old) as a single dose for COVID-19 immunisation. Medical history included herpes. The patient did not receive any medication within two weeks of vaccination. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EW0173) via an unspecified route of administration in the left arm on 03May2021 at 13:00 (at the age of 44-years-old) as a single dose for COVID-19 immunisation. The patient previously received cefadroxil (MANUFACTURER UNKNOWN) on an unknown date for unknown indication and experienced drug allergy. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 24May2021 at 18:00, within a few hours, the patient experienced herpes outbreak. The event did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures were taken as a result of herpes outbreak and included treatment with VALTREX. The clinical outcome of the event herpes outbreak was not resolved at the time of report.  No follow-up attempts are possible. No further information is expected.
Treatment of COVID-19; Treatment of COVID-19; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 57-year-old female patient (not pregnant) received BNT162b2 (BNT162B2), on 26Feb2021 as dose 2, single (Lot number: EN6198) at the age of 56 years, in left arm for covid-19 immunisation; coviD-19 vaccine mrna (mrna 1273) (MODERNA COVID-19 VACCINE), on 30Dec2021 as dose 3 (booster), single (Lot number: 032h21a) for covid-19 immunisation; coviD-19 vaccine (COVID-19 VACCINE), as dose 1, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history included: "BMI 26" (unspecified if ongoing); "Prediabetes" (unspecified if ongoing). Concomitant medication(s) included: ESTRACE; PROVERA. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant), outcome "unknown" and all described as "Treatment of COVID-19". The patient underwent the following laboratory tests and procedures: Body mass index: 26, notes: Unit not mentioned only digit captured; SARS-CoV-2 test: Positive. Therapeutic measures were taken as a result of drug ineffective, covid-19.  Clinical information: The patient had no known allergies. The patient took treatment for Covid-19 with Paxlovid on 27Jul2022. The patient has taken 4 doses of Paxlovid. Last night she took the dose at 7:30 pm.
Nurse sent us an email that their employee had been vaccinated with the PFizer Covid 19 Vaccine and had a reaction. He has had diarrhea and fatigue since the 9th of January. He was advised by his nephrologist to get the vaccine. He has Lupus and CKD4 and is also on the drug Cellcept.
Positive COVID test; This is a spontaneous report from a contactable consumer (patient). A 41-years-old male patient received his first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; lot number EL3246, expiration date Apr2021), via an unspecified route of administration, administered in Arm Right on 18Jan2021 (age at vaccination of 41-years-old) as single dose for covid-19 immunisation. Medical history included blood donation from an unknown date and unknown if ongoing. There were no concomitant medications.  The patient was tested positive for COVID-19 on 23Jan2021. COVID test says he is negative nowand he wants to know if he can get the second COVID-19 Vaccine. Outcome of the event was recovered on an unspecified date.
-chills, dizziness, and bad headache -pain from shot area  -still having symptoms as of 8/6/21
Redness at site vaccine (R) thigh and swelling. Mild tenderness 4x2.
Measles rash - fine red raised rash to bilat. cheeks et posterior trunk.
I?m sick with cold sweats, headaches, wheezing cough whenever I take a deep breath, extreme fatigue, little appetite, and diarrhea . But I can taste and smell. I?ve been this way for over week.
The day after he received the second dose, he developed severe pain and stiffness in the fingers of both hands, which has persisted for 30 days.
This spontaneous report as received from a registered nurse refers to a patient of unknown age and gender who on 06-DEC-2012, was vaccinated with an expired dose of PNEUMOVAX 23 (dose and route not reported) (lot # 667274/083Z, Exp: 12-DEC-2011). No symptoms reported. Additional information is not expected.
After flu shot was received patient had a sore arm, soreness from fingers to shoulders.  Ibuprofen has relieved pain for short periods of time, pain has persisted to present day.
I would have frequent episodes that felt as if I had a rapid and irregular heart rate, probably 15 or so a day at the peak. I also noticed this after my second dose of the Pfizer vaccine but chalked it up to dehydration and didn't seek treatment. After the booster in December of 2021 it was more intense and lasted much longer, so I decided to see a doctor.  For what it is worth I have never experienced episodes like this in my life save for about a week after the second dose of the Pfizer covid shot and about a week after the booster. My symptoms have totally gone away and my doctor told me to follow up only if they start happening again.
4 days later (5/1/2021) anaphylactic shock after a bee sting. No allergy to bee stings before. Whole body rash with severe itching, swelling in mouth and throat, extreme weakness, close to fainting  within minutes. Emergency room visit, EPI pen injection, steroid injection, EKG, chest x-ray, blood work. 4 hours of observation in hospital. Still weak today, voice weak, and can't seem to take in enough oxygen to go on a walk or do simple yoga stretches.
Uncontrolled hypertension, NSTEMI (non-ST elevated myocardial infarction) (HCC). ED visit and hospital admission. This visit is within 6 weeks of receiving the COVID vaccine.
This spontaneous report as received from a medical assistant referring to an unspecified number of patients (ages and gender not specified). Concurrent conditions, medical history and concomitant medication use were not provided.  The medical assistant reported that the patients received unspecified doses of VARIVAX, (lot# L045954, exp. date 17-NOV-2017, lot# L041204 exp. date 20-OCT-2017, and lot# M006722, exp. date 08-FEB-2018) immunization series that were improperly stored at -13.1 C for 30 minutes between the dates of 06-JUL-2016 and 11-JUL-2016. No adverse effects were reported. The outcome of the event was not provided. Additional information has been requested.
Extreme fatigue and dizziness. Headache. Nausea. Elevated heart rate (129)
A report has been received from a physician via medical rep, concerning multiple patients of unknown ages and genders. No relevant history, concomitant disease or concomitant medications of the patients were reported. The patients had received FLUMIST (Intranasal). It was reported that there were several breakthrough cases of Influenza. Action taken with influenza virus vaccine live, intranasal was unknown. The outcome of the event of several breakthrough cases of influenza was unknown. The reporter assessed the event of several breakthrough cases of influenza to be non-serious.
Information has been received from a registered nurse concerning a 22 year old female with asthma, sulfonamide allergy, shrimp allergy and latex sensitivity who on 15-JAN-2007, in the morning was vaccinated with Pneumovax 23 vaccine (lot number 655152/0889F), intramuscularly in right lower deltoid. The patient was also given influenza virus vaccine (unspecified) concomitantly in the upper deltoid of the right arm. Concomitant therapy also included MACROBID, ORTHO-TRI-CYCLEN. On 15-JAN-2007, in the evening, the patient experienced temperature of 100.4 degrees F, redness, swelling and pain at injection site, On 16-JAN-2007, the patient was seen in the physician's office and the injection site reaction was described as red, swollen area with cellulitis measuring 4 cm that was painful to the touch. The patient also complained of muscle weakness, and could not lift the injection arm. On 17-JAN-2007 the patient was again examined in the physician's office and the cellulitis was measured to be 9 cm and was still painful and tender to touch. The patient also complained of generalized malaise and hip pain the preceding day. The patient continued to report a temperature of 100.4F but when the temperature was measured in the physician's office it was recorded to be 97.2F on 16-JAN-2007, and 98.2 on 17-JAN-2007. The patient is considered not recovered as of 17-JAN-2007. The physician's office is requesting a lot check. Cellulitis of the injection arm, hip pain, temperature of 100.4 degrees F, redness and swelling and pain of the injection site, generalized malaise and muscle weakness were considered disabling. Additional information has been requested.
This is a spontaneous report from a non-contactable consumer or other non hcp (patient). A 42-year-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection), dose 2 via an unspecified route of administration, administered in Arm Left on 24Mar2021 15:00 (Batch/Lot Number: EL3248) as dose 2, single, dose 1 via an unspecified route of administration on an unspecified date (Batch/Lot number was not reported) as dose 1, single for covid-19 immunisation. The patient medical history and concomitant medications were not reported. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. No known allergy. No other medical history. The patient was not pregnant at the time of vaccination. On 25Mar2021(13 hour after injection), the patient experienced mild fever, body aches, muscle soreness, headache, fatigue, some swelling initially at injection site leading to pain under left armpit area. Therapeutic measures were taken as a result of event includes TYLENOL. The outcome for all events was recovered on unknown date in 2021. No follow-up attempts are needed. No further information is expected.
This spontaneous report as received from a office manager to a 11 years old female patient. The patient was vaccinated with the first dose of GARDASIL (lot# 0636AE) on 21-JAN-2013. No other co-suspects were reported. Concomitant medications included Influenza Virus Vaccine (manufacture unknown) and meningococcal vaccine (manufacture unknown). On 21-JAN-2013 the patient experienced fainted after the administration. The office called the paramedics and the patient was sent to the emergency room at an unspecified hospital for an unspecified duration. No treatment information was reported. The outcome of fainted was unknown. The relatedness for fainted was unknown for GARDASIL. Additional information is not expected.
Extreme itchiness, inflammation, red, hot skin started around ears and neck. Then proceeded to entire body. Very uncomfortable and also fever (slight).
couldn't sleep; patient was told maybe had a pinched nerve and that maybe came from neck; get unbelievably pain in his arm, crying howbad the pain was on his arm; severe pain; This spontaneous case was reported by a patient family member or friend and describes the occurrence of PAIN (severe pain), INSOMNIA (couldn't sleep), NERVE COMPRESSION (patient was told maybe had a pinched nerve and that maybe came from neck) and PAIN IN EXTREMITY (get unbelievably pain in his arm, crying howbad the pain was on his arm) in a 31-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 059a22a) for COVID-19 vaccination.     Previously administered products included for Product used for unknown indication: Pfizer (Dose-1) on 05-Apr-2021, Pfizer (Dose-2) on 26-Apr-2021 and Pfizer (1st Booster dose) on 06-Aug-2021. Past adverse reactions to the above products included No adverse event with Pfizer, Pfizer and Pfizer.    On 21-Jun-2022, the patient received fourth dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. In June 2022, the patient experienced PAIN (severe pain). On 05-Jul-2022, the patient experienced INSOMNIA (couldn't sleep), NERVE COMPRESSION (patient was told maybe had a pinched nerve and that maybe came from neck) and PAIN IN EXTREMITY (get unbelievably pain in his arm, crying howbad the pain was on his arm). The patient was treated with IBUPROFEN (MOTRIN [IBUPROFEN]) at an unspecified dose and frequency; PARACETAMOL (TYLENOL) at an unspecified dose and frequency; CORTISONE at a dose of cortisone in his neck; PREDNISONE at a dose of prednisone shot pack and GABAPENTIN at an unspecified dose and frequency. At the time of the report, PAIN (severe pain), INSOMNIA (couldn't sleep), NERVE COMPRESSION (patient was told maybe had a pinched nerve and that maybe came from neck) and PAIN IN EXTREMITY (get unbelievably pain in his arm, crying howbad the pain was on his arm) had not resolved.            No concomitant medication information provided. Patient did not have any allergies. It was reported that the patient was very healthy. It was reported that, following vaccination with the second booster the patient had severe pain on the 27 or 28-Jun-2022, on 05-Jul-2022 went to the emergency room, patient was told that maybe he had a pinched nerve in the emergency room, and that maybe came from his neck in a orthopedic walking clinic. The patient was given "all kind of medicines".  Patient took steroid shot and 2 more shots as treatment.
Had zero adverse effects from 1st dose, but 2nd dose I went to bend feeling fine then woke up at 01:30 a.m. burning up head to toe and extreme body aches. I had to take max dose of Tylenol and sleep on  6 six packs over my hold body just to take the edge off. I had to do this for 4 hours. After that I spent the next 24 hours with body aches and exhaustion.
Developed pulmonary fluid and difficulty breathing after 2nd Covid vaccine in March 2021. Died from pulmonary edema and heart failure 9 days after 3rd dose.
Patient slumped to floor in vaccination waiting room. Parents caught her and no head injury. Patient laid on floor and was disoriented for 30 seconds. Heart rate and breathing rate within normal limits. After patient disorientation passed, she drank water and was monitored in waiting rom for an additional 15 minutes and no return of syncope symptoms. No EMS called to location. Patient has had history of fainting but not after a vaccine until now.
herpes zoster; This spontaneous report has been received from a lawyer regarding a case in litigation, concerning a female patient of unknown age. The patient's medical history, concurrent conditions or concomitant medications were not provided. On or about 02-FEB-2015, the patient was vaccinated with zoster vaccine live (ZOSTAVAX) (strength, lot #, expiration date, dosage, anatomical location and route of administration were not reported) at a pharmacy, as prescribed by a healthcare provider for the long-term prevention of shingles and zoster-related conditions. Shortly after vaccination, she was diagnosed with herpes zoster caused by zoster vaccine live (ZOSTAVAX). As a result, the patient claimed damages of injury, loss of consortium, loss of services and economic losses. The outcome for herpes zoster was not reported.
RespDepression SOB, eye swollen, face red, pepcid, claritin
The vaccine injection site is a "buldge" that is red and has a rash underneath the skin. It is warm to the touch; but I do not have a fever. It itches.  The site was find after the injection, but reaction occured at the later date.
Developed PII(28): palsy; This spontaneous case was reported by an other health care professional and describes the occurrence of BELL'S PALSY (Developed PII(28): palsy) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced BELL'S PALSY (Developed PII(28): palsy) (seriousness criterion medically significant). At the time of the report, BELL'S PALSY (Developed PII(28): palsy) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medication information provided No treatment medication information provided  patient developed PII(28): palsy a month after my booster shot is there any known side effect like that  Company comment: This spontaneous case concerns a patient with no relevant medical history reported who experienced serious expected event of Bell's palsy. The event occurred approximately a month after the booster dose of the mRNA-1273 .Rechallenge was not applicable since the event occurred after the second dose so, no rechallenge was done and recurrence was not applicable.  The benefit-risk relationship of mRNA-1273 is not affected by this report.; Sender's Comments: This spontaneous case concerns a patient with no relevant medical history reported who experienced serious expected event of Bell's palsy. The event occurred approximately a month after the booster dose of the mRNA-1273 .Rechallenge was not applicable since the event occurred after the second dose so, no rechallenge was done and recurrence was not applicable.  The benefit-risk relationship of mRNA-1273 is not affected by this report.
shortness of breath and hypoxia, requiring hospitalization. Treated with oxygen delivery via HFNC as well as steroids and lovenox
Fever, muscle pain, chills, cold sweats, headachess, dizziness, extreme swelling at injection site lasting 3 days.
This spontaneous report as received from a nurse refers to a 19 year old patient. On 07-JUL-2014, the patient was vaccinated with first dose of VAQTA (dose, route and frequency were not reported). The nurse reported that on 07-JUL-2014, the patient received second dose of VAQTA at 19 years of age. No adverse symptoms reported. No further information provided. Additional information has been requested.
Information has been received from a physician via Pfizer referring to a 56 year old male patient with allergic to insulin beef, mycins, MMR II vaccine (captured in case# 1510USA008402), REGLAN, KEFLEX, TIAZAC and DARVOCET-N 100. The patient was a former smoker and did not drink alcohol. He quit smoking in 2013. On an unknown date the patient was vaccinated with a dose of zoster vaccine live (manufacturer unknown) (dose, route, lot# and expired date were unknown). No concomitant therapy was reported. On an unknown date the patient experienced allergy to the vaccine. The outcome of the event was unknown. Additional information has been requested.
Blood pressure started to elevate and was having occasional palpitations.  I was placed on Norvasc 2.5 mg daily, 3 months after vaccination to control BP.  Had an episode of increased blood pressure, severe palpitations, chest pain and pulse 124 bpm on Dec 16th.  I had to go to the Emergency room via ambulance to be evaluated.  I received my Pfizer booster on 10/6/2021.  Blood pressure continued to be elevated.  Doctor increased Norvasc to 5 mg daily.
rash all over; This is a spontaneous report from a contactable consumer.   A 71-year-old female patient BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number was not reported), dose 1 via an unspecified route of administration, administered in left arm on 10Feb2021, at 09:45 as single dose for covid-19 immunization.  The patient medical history was not reported.   There were unspecified concomitant medications.   On 18Feb2021, at 08:00 patient experienced rash all over ( this occurred eight days the vaccine was given) and described as terrible rash all over her body.  Therapeutic measures were taken as a result of rash all over in the form of prednisone cream. The patient did not have COVID prior to vaccination, and no COVID test post vaccination. The outcome of  rash all over  was not recovered.   The batch/lot number for the vaccine, BNT162B2, was not provided and will be requested during follow-up.
Given 2nd in series of Hep B vaccine. Developed frontal H/A 45mins later as she had with 1st dose. 1 hour post injection she started to have difficulty swallowing and then started to wheeze. Difficulty swallowing and wheezing worsened rapidly. She stated she could not breathe. She was spitting up thick white phlegm. EPI 0.2cc given Sp and O2 per/cc. Symptoms rapidly cleared.
wife reports - chills, increased thirst, headache, achy, tachycardia - heart rate up to 180 - states had to use "emergency medication"
Rash, fever, nausea, vomiting, itching, pale, pharynx inflammed, small vesicles on trunk, face, and extremities.
diluent was not reconstituted with the powder; diluent was not reconstituted with the powder; This case was reported by a other health professional via call center representative and described the occurrence of inappropriate preparation of medication in a 52-year-old female patient who received Herpes zoster (Shingrix) (batch number J5255, expiry date 13th November 2022) for prophylaxis.   On 9th August 2021, the patient received the 1st dose of Shingrix. On 9th August 2021, unknown after receiving Shingrix, the patient experienced inappropriate preparation of medication and inappropriate dose of vaccine administered. On an unknown date, the outcome of the inappropriate preparation of medication and inappropriate dose of vaccine administered were unknown.  Additional details were provided as follows: The reporter stated that, the patient received only the diluent portion of the Shingrix, the diluent was not reconstituted with the powder and only the adjuvant was given, which led to inappropriate preparation of medication and inappropriate dose of vaccine administered. The reporter consented to follow up via email. This case was linked with case US2020222258, reported by same reporter for different patient.; Sender's Comments:  US-GLAXOSMITHKLINE-US2020222258:Same reporter
Site became red and warm no swelling. Size of fifty cent piece. Started day of shot it is starting to fade now states aunt. Aunt was encouraged to watch, give pt BENADRYL and apply ice off and on as needed. If no changes call office back 8/3/10. Aunt voiced understanding.
Pt. was mildly ill with tonsillitis when vaccine given. 2 days later went to urgent care for worsening (throat swelling). 2 days later went to hospital ED for throat swelling and transported to another hospital. In PICU now x 3 days on ventilator. They think severe EBV infection, but unsure.
pt recv vax 24SEP96 & 26SEP96 pt exp sore throat, malaise & cold type sx;MD also described the sx as prodromal sx;
The shot made me very sick; This non-serious case was reported by a consumer via interactive digital media and described the occurrence of sickness in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   In JAN-2023, the patient received the 1st dose of Shingles vaccine. On an unknown date, an unknown time after receiving Shingles vaccine, the patient experienced sickness (Verbatim: The shot made me very sick). The outcome of the sickness was not reported.   It was unknown if the reporter considered the sickness to be related to Shingles vaccine.     It was unknown if the company considered the sickness to be related to Shingles vaccine.   Additional Information: GSK receipt date: 13-Mar-2023 The case was received from the patient via interactive digital media. The patient got the first shingles shot in January and will get his/her second one in April and the shot made him/her very sick. The follow-up could not be possible as no contact details were available.
Med Error-Gray top Pfizer given to an 11 year old. No adverse events.